RSNA 2018 News

Guerbet offers multiuse version of OptiVantage injector

By staff writers
November 27, 2018

Contrast developer Guerbet is launching a multiuse version of its OptiVantage syringe-based injector at RSNA 2018 in Chicago.

The injector is used to administer contrast agents for CT scans, and the new version is adapted to multiuse markets and is available in pedestal and ceiling-mount versions.

The new multiuse/patient version includes the Opti-Vantage syringe-based injector; a complete range of associated syringes and disposables, including the manyFill day set and secufill patient line; services, and the support system of OptiProtect.

Customers already using the injector may request an upgrade to get the multiuse version, according to the company.

Guerbet also announced that multiuse OptiVantage has received the CE Mark in Europe, paving the way for launch in that region in January.

Guerbet names North American marketing head
Contrast developer Guerbet has appointed Leeann Essai as its North American head of marketing.
Guerbet to highlight new contrast kit at CIRSE
Contrast developer Guerbet plans to showcase Vectorio, a new contrast media kit for diagnostic and interventional imaging, at the upcoming Cardiovascular...
Guerbet teams with Imalogix on dose-tracking software
Guerbet USA has formed a commercial partnership with radiation dose-tracking software developer Imalogix.
Guerbet contributes to AHRA campaign
Contrast developer Guerbet has made a $50,000 charitable contribution to the AHRA's Defining Our Future leadership campaign.
Guerbet, IBM Watson Health to collaborate on AI software
French contrast developer Guerbet has signed an exclusive agreement with IBM Watson Health to jointly develop artificial intelligence (AI) software for...

Copyright © 2018

Last Updated np 11/26/2018 11:48:40 PM